Paper17276366
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
Kogelnik AM and 5 others. J Clin Virol, 2006. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Papers, record 17276366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17276366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Diseases | Major topic |
| Epstein-Barr Virus Infections | Major topic |
| Fatigue Syndrome, Chronic | Major topic |
| Ganciclovir | Major topic |
| Roseolovirus Infections | Major topic |
| Administration, Oral | |
| Adult | |
| Antibodies, Viral | |
| Antiviral Agents | |
| Female | |
| Herpesvirus 4, Human | |
| Herpesvirus 6, Human | |
| Humans | |
| Immunoglobulin G | |
| Male | |
| Middle Aged | |
| Valganciclovir |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1 F37 LM008480-01 | NLM NIH HHS | United States | F37LM008480 | PubMed and NIH |
Source NIH RePORTER
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797874 | High Frequency of HHV-7 Reactivation in Neurological and Neuropsychiatric Long COVID: A Retrospective Observational Study. | Viruses | 2026 | https://conductscience.org/library/papers/42797874 | PubMed |
| 41472292 | Does Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Represent a Poly-Herpesvirus Post-Virus Infectious Disease? | Viruses | 2025 | https://conductscience.org/library/papers/41472292 | PubMed |
| 40076522 | Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Aetiology and Potential Treatments. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076522 | PubMed |
| 39326415 | Mechanisms of long COVID and the path toward therapeutics. | Cell | 2024 | https://conductscience.org/library/papers/39326415 | PubMed |
| 39201991 | Long COVID Is Not a Functional Neurologic Disorder. | J Pers Med | 2024 | https://conductscience.org/library/papers/39201991 | PubMed |
| 38361801 | Insights into the interplay between Epstein-Barr virus (EBV) and multiple sclerosis (MS): A state-of-the-art review and implications for vaccine development. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/38361801 | PubMed |
| 38256459 | Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives. | J Clin Med | 2024 | https://conductscience.org/library/papers/38256459 | PubMed |
| 37718435 | Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID? | J Transl Med | 2023 | https://conductscience.org/library/papers/37718435 | PubMed |
| 36969241 | Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. | Front Immunol | 2023 | https://conductscience.org/library/papers/36969241 | PubMed |
| 36101642 | Back to the Future: The Role of Infections in Psychopathology. Focus on OCD. | Clin Neuropsychiatry | 2022 | https://conductscience.org/library/papers/36101642 | PubMed |
| 35606640 | Therapeutic Implications of the Microbial Hypothesis of Mental Illness. | Curr Top Behav Neurosci | 2023 | https://conductscience.org/library/papers/35606640 | PubMed |
| 34026797 | Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34026797 | PubMed |
| 32664492 | Low Vitamin D States Observed in U.S. Marines and Navy Sailors with Early Multi-Symptom Illness. | Biomolecules | 2020 | https://conductscience.org/library/papers/32664492 | PubMed |
| 31911410 | Low-dose naltrexone as a treatment for chronic fatigue syndrome. | BMJ Case Rep | 2020 | https://conductscience.org/library/papers/31911410 | PubMed |
| 31807568 | Efficacy and safety of Sijunzi Decoction for chronic fatigue syndrome with spleen deficiency pattern: study protocol for a randomized, double-blind, placebo-controlled trial. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/31807568 | PubMed |
| 30871727 | Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary. | Clin Ther | 2019 | https://conductscience.org/library/papers/30871727 | PubMed |
| 28303641 | Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology. | J Med Virol | 2017 | https://conductscience.org/library/papers/28303641 | PubMed |
| 28036046 | Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease. | Pathogens | 2016 | https://conductscience.org/library/papers/28036046 | PubMed |
| 25746727 | Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial. | PLoS One | 2015 | https://conductscience.org/library/papers/25746727 | PubMed |
| 25462447 | The development of new therapies for human herpesvirus 6. | Curr Opin Virol | 2014 | https://conductscience.org/library/papers/25462447 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17276366
GET https://conductscience.org/api/papers/v1/17276366/cited_by?page=2